Targeting botulinum A cellular toxicity: a prodrug approach

Area of Science:

• Biochemistry
• Neuroscience
• Medicinal Chemistry

Background:

• Botulinum neurotoxin light chain (LC) protease is a key therapeutic target for botulism.
• Hydroxamic acid inhibitors show high potency but lack cellular activity due to poor membrane permeability.

Purpose of the Study:

• To investigate prodrug strategies (1,4,2-dioxazole and carbamate) to enhance cellular delivery of botulinum neurotoxin LC inhibitors.
• To develop small molecules with improved cell permeability and efficacy for postexposure botulism treatment.

Main Methods:

• Synthesis and evaluation of 1,4,2-dioxazole and carbamate prodrugs based on a 1-adamantylacetohydroxamic acid scaffold.
• Assessment of cellular activity and potency (EC50) of the developed prodrugs.
• Cellular trafficking studies using a fluorescently silent prodrug to visualize intracellular release.

Main Results:

• Carbamate prodrugs demonstrated cellular activity, with the most potent compound showing an EC50 of 20 μM.
• The 1,4,2-dioxazole prodrug strategy did not yield significant cellular activity.
• Cellular trafficking studies successfully visualized intracellular drug release within neuronal cells.

Conclusions:

• Carbamate prodrugs represent a viable strategy for improving the cellular delivery and efficacy of botulinum neurotoxin LC inhibitors.
• This research provides a foundation for developing targeted neuronal delivery of antibotulinum agents.
• Further studies are warranted to optimize these prodrugs for therapeutic applications against botulism.